Search research articles
Contact Us
Filters
Showing results (31-40 of 57) with videos related to
Page
of 6
Sort By:
Oncology Letters
|
March 12, 2019
Erastin decreases radioresistance of NSCLC cells partially by inducing GPX4-mediated ferroptosis
Xiaofen Pan, Zhixiu Lin, Danxian Jiang, et al.
Oncology Reports
|
June 15, 2018
Enhanced expression of SETDB1 possesses prognostic value and promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma
Jing Huang, Weiyuan Huang, Mei Liu, et al.
Oncology Letters
|
August 8, 2017
Niclosamide enhances the antitumor effects of radiation by inhibiting the hypoxia-inducible factor-1α/vascular endothelial growth factor signaling pathway in human lung cancer cells
Mei Xiang, Zihong Chen, Donghong Yang, et al.
Science Advances
|
November 17, 2021
Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibition
Hongyu Ding, Zihong Chen, Katherine Wu, et al.
Cancer Research
|
July 15, 2020
Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras-Driven Tumor Growth or Metastasis
Jonathan M Ghergurovich, Mark Esposito, Zihong Chen, et al.
Biochemical Genetics
|
November 10, 2025
Identification of the Dynamic Expression Patterns of Immune Genes in the Peripheral Blood of Acute Ischemic Stroke Patients
Jingnan Jin, Lifang Li, Danyang Li, et al.
Journal of Virology
|
November 10, 2006
GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS
Zihong Chen, Yann Benureau, Rene Rijnbrand, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 3, 2025
Oxidative pentose phosphate pathway is required for T cell activation and antitumor immunity
Zihong Chen, Kellen L Olszewski, Rolf-Peter Ryseck, et al.
Journal of Cancer
|
March 21, 2018
Niclosamide sensitizes nasopharyngeal carcinoma to radiation by downregulating Ku70/80 expression
Jingjing Li, Haiwen Li, Dechao Zhan, et al.
Medcomm
|
July 10, 2025
Phase I Clinical Trial of CVL218, a Novel PARP1/2 Inhibitor, in Patients with Advanced Solid Tumors
Zihong Chen, Gang Chen, Yuxiang Ma, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 57) with videos related to
Sort By:
Page
of 6
Oncology Letters
|
March 12, 2019
Erastin decreases radioresistance of NSCLC cells partially by inducing GPX4-mediated ferroptosis
Xiaofen Pan, Zhixiu Lin, Danxian Jiang, et al.
Oncology Reports
|
June 15, 2018
Enhanced expression of SETDB1 possesses prognostic value and promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma
Jing Huang, Weiyuan Huang, Mei Liu, et al.
Oncology Letters
|
August 8, 2017
Niclosamide enhances the antitumor effects of radiation by inhibiting the hypoxia-inducible factor-1α/vascular endothelial growth factor signaling pathway in human lung cancer cells
Mei Xiang, Zihong Chen, Donghong Yang, et al.
Science Advances
|
November 17, 2021
Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibition
Hongyu Ding, Zihong Chen, Katherine Wu, et al.
Cancer Research
|
July 15, 2020
Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras-Driven Tumor Growth or Metastasis
Jonathan M Ghergurovich, Mark Esposito, Zihong Chen, et al.
Biochemical Genetics
|
November 10, 2025
Identification of the Dynamic Expression Patterns of Immune Genes in the Peripheral Blood of Acute Ischemic Stroke Patients
Jingnan Jin, Lifang Li, Danyang Li, et al.
Journal of Virology
|
November 10, 2006
GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS
Zihong Chen, Yann Benureau, Rene Rijnbrand, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 3, 2025
Oxidative pentose phosphate pathway is required for T cell activation and antitumor immunity
Zihong Chen, Kellen L Olszewski, Rolf-Peter Ryseck, et al.
Journal of Cancer
|
March 21, 2018
Niclosamide sensitizes nasopharyngeal carcinoma to radiation by downregulating Ku70/80 expression
Jingjing Li, Haiwen Li, Dechao Zhan, et al.
Medcomm
|
July 10, 2025
Phase I Clinical Trial of CVL218, a Novel PARP1/2 Inhibitor, in Patients with Advanced Solid Tumors
Zihong Chen, Gang Chen, Yuxiang Ma, et al.
Page
of 6